About
Technology
Issues
FAQ
Links
Official Page
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.